The Searle Company Limited (PSX:SEARL)
105.13
-4.34 (-3.96%)
At close: Nov 11, 2025
The Searle Company Revenue
The Searle Company had revenue of 9.70B PKR in the quarter ending September 30, 2025, with 27.19% growth. This brings the company's revenue in the last twelve months to 30.67B, up 8.32% year-over-year. In the fiscal year ending June 30, 2025, The Searle Company had annual revenue of 28.60B, down -2.72%.
Revenue (ttm)
30.67B
Revenue Growth
+8.32%
P/S Ratio
2.02
Revenue / Employee
8.07M
Employees
3,799
Market Cap
61.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 28.60B | -800.84M | -2.72% |
| Jun 30, 2024 | 29.40B | 3.60B | 13.97% |
| Jun 30, 2023 | 25.80B | -4.11B | -13.75% |
| Jun 30, 2022 | 29.91B | 3.69B | 14.07% |
| Jun 30, 2021 | 26.22B | 5.74B | 28.06% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 74.84B |
| GlaxoSmithKline Pakistan | 62.07B |
| Shifa International Hospitals | 28.52B |
| AGP Limited | 27.73B |
| Highnoon Laboratories | 26.61B |
| Ferozsons Laboratories | 20.27B |
| Citi Pharma | 13.30B |
| Macter International | 10.96B |